Ophthalmology

Top Story

Cover Story: Ocular anesthesia trends toward 'fewer needles, no pain'

September 25, 2016

Various innovations in technology and methods have revolutionized ocular surgery by maximizing outcomes and safety, shortening surgical time and reducing stress on patients.

Patient comfort and immobility are also critical to surgical success and safety, and anesthesia plays a key role. Currently, ophthalmic surgeons use intravenous sedation and topical or infiltration methods such as retrobulbar anesthesia, peribulbar anesthesia and subconjunctival anesthesia to achieve akinesia.

Meeting News CoverageVideo

VIDEO: Astigmatism management an issue in all types of ocular surgery

September 24, 2016
COPENHAGEN – Béatrice Cochener, MD, PhD, president elect of the European Society of Cataract and Refractive Surgeons, talks about management of…

STAAR Surgical receives approval of EVO Visian toric ICL from Health Canada

September 23, 2016
STAAR Surgical announced the Medical Devices Bureau of Health Canada approved the EVO Visian toric ICL for distribution in Canada. In contrast to traditional contact…

Heidelberg receives FDA clearance to market Spectralis OCT glaucoma module

September 23, 2016
Heidelberg Engineering received 510(k) clearance from the FDA to market the Spectralis OCT Glaucoma Module Premium Edition, which creates an anatomic map unique to each…
In the Journals

Survey shows extensive support for nationwide precision medicine study

September 23, 2016
A majority of adults expressed support of and willingness to participate in the Precision Medicine Initiative’s national research effort, according to recent…
More News Headlines »
Original Article

Congenital Nasolacrimal Duct Obstruction: Comparison of Two Different Treatment Algorithms

Journal of Pediatric Ophthalmology and Strabismus, September/October 2016, Volume 53 Issue 5
To clarify the most appropriate treatment regimen for congenital nasolacrimal duct obstruction (CNLDO). A retrospective…
More »
CME

Key Components in the Design and Execution of a Successful Clinical Trial

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Featured
Video
Meeting News Coverage

VIDEO: Astigmatism management an issue in all types of ocular surgery

September 24, 2016
More »
morganatic-roan
morganatic-roan